Pharmaceutical company, Merck & Co., has recently made a 3rd attempt to make the cholesterol lowering drug, Mevacor, available to consumers over-the-counter.
Merck & Co. defended their case by arguing that only 6 million of 20 million Americans who have moderately high cholesterol are being treated. Merck believes that consumers have enough knowledge about heart-clogging cholesterol to use the drug properly.
The FDA’s scientific advisors will make a recommendation on Thursday, December 14th. However, they don’t know how long it will be to officially come to a decision on the issue.
For more information on this subject, please refer to the section on Mevacor / Lovastatin: Overview.